Nanfang Hospital, Southern Medical University | China.

Author Profile

🎓Education

Dr. Cao holds a strong educational background in medical and molecular sciences, specializing in oncology. His academic foundation has equipped him to explore the complexities of liver cancer at the molecular level, bridging clinical applications and innovative research.

💼Professional Experience

Dr. Cao serves as an Associate Professor and Attending Physician. With a supervisory role, he guides doctoral and postdoctoral scholars, nurturing the next generation of researchers. His expertise extends into translational oncology, focusing on treatment resistance and tumor biology.

🔬Technical Skills

Molecular Biology Techniques: Single-cell transcriptomics, gene editing, and RNA sequencing

Clinical Oncology: Precision radiotherapy, immune checkpoint inhibitor research

📚Academic Contributions

Standing Committee Member, Radiation Oncology Professional Committee, Guangdong Hospital Association

Standing Committee Member, Tumor Diagnosis and Treatment Technology Transformation Professional Committee, Guangdong Medical Education Association

Member, Precision Radiotherapy Branch, Guangdong Society of Precision Medicine.

🔬Research Interests

Dr. Cao is dedicated to understanding the molecular mechanisms underlying liver cancer, with a focus on treatment resistance, tumor microenvironment, and immunotherapy enhancements.

🏆Awards and Honors

Guangzhou “Pearl River Science and Technology Rising Star” (2019)

First Prize, Guangdong Provincial Natural Science Award

🔬Funded Research Projects

Mechanisms of PFOS-induced differentiation of stem-like CD8+ T cells, promoting liver cancer progression (2025–2028)

AXIN1 mutation and radiotherapy efficacy (2021–2024)

Long non-coding RNA AP000695.4 in liver cancer progression

📘Teaching Experience

As a doctoral and postdoctoral mentor, Dr. Cao has contributed significantly to academic training, guiding research projects and facilitating translational research in liver cancer.

📑Notable Publications

“Antiangiogenic Treatment Facilitates the Abscopal Effect of Radiation Therapy Combined With Anti-PD-1 in Hepatocellular Carcinoma”

Authors: Sheng, H.; Luo, Y.; Zhong, L.; … Sun, J.; Cao, C.
Publication Year: 2025
Journal: International Journal of Radiation Oncology Biology Physics

“Diethylhexyl phthalate induces immune dysregulation and is an environmental immune disruptor”

Authors: Linghu, D.; Zhu, Z.; Zhang, D.; … Sun, J.; Cao, C.
Publication Year: 2024
Journal: Journal of Hazardous Materials

“Polystyrene microplastics aggravate radiation-induced intestinal injury in mice”

Authors: Chen, Y.; Zeng, Q.; Luo, Y.; … Sun, J.; Cao, C.
Publication Year: 2024
Journal: Ecotoxicology and Environmental Safety

“Single-cell transcriptomics reveal the microenvironment landscape of perfluorooctane sulfonate-induced liver injury in female mice”

Authors: He, X.; Sun, Z.; Sun, J.; … Song, M.; Cao, C.
Publication Year: 2024
Journal: Science of the Total Environment

“Overexpression of ubiquitin-conjugating enzyme 2T induces radiotherapy resistance in hepatocellular carcinoma by enriching regulatory T cells in the tumor microenvironment | UBE2T 通过调节性 T 细胞诱导肝细胞癌的放疗抵抗”

Authors: He, X.; Xiong, S.; Zhu, Z.; … Cao, C.; Wang, H.
Publication Year: 2024
Journal: Nan Fang Yi Ke Da Xue Xue Bao / Journal of Southern Medical University

Guang-Yu Pan | Antimicrobial | Best Researcher Award

Dr. Guang-Yu Pan, Guilin Medical University, China.

Dr. Guang-Yu Pan is an Associate Professor of Biomedical Engineering at Guilin Medical University, Guilin, China. He earned his Ph.D. from Southeast University in 2018 and joined Guilin Medical University the same year. Promoted to Associate Professor in 2022, Dr. Pan specializes in antimicrobial materials, hemostatic agents, and tissue regeneration materials, addressing critical challenges in healthcare. He has published seven first-author or corresponding-author papers in prestigious international journals, including ACS Applied Nano Materials, Nanoscale, and International Journal of Biological Macromolecules. Dr. Pan’s innovative research continues to advance the frontiers of biomedical engineering.

Professional Profiles

Scopus Profile

Orcid Profile

📚Education

Dr. Pan completed his Ph.D. in Biomedical Engineering at Southeast University, Nanjing, China, in 2018, focusing on advanced biomaterials for medical applications. He earned his M.Sc. in Biomedical Engineering from the same institution in 2015, specializing in material characterization and biomaterial innovations. He began his academic journey at Guilin Medical University, where he completed his B.Sc. in Biomedical Engineering in 2012, focusing on the fundamentals of medical materials and engineering principles.

💼Experience

Dr. Pan began his professional career at Guilin Medical University in 2018 as a Lecturer in Biomedical Engineering. In 2022, he was promoted to Associate Professor, recognizing his exceptional contributions to research and teaching. His professional experience combines academia, research innovation, and leadership in advancing biomedical solutions.As a dedicated educator, Dr. Pan teaches undergraduate and postgraduate courses in Biomedical Engineering. His teaching focuses on biomaterials, tissue engineering, and the medical applications of material science. He integrates his research findings into the curriculum, providing students with a cutting-edge understanding of the field.

🔬Research Interest

Dr. Pan’s research centers on antimicrobial materials, addressing infections and improving healthcare outcomes. He also focuses on the development of hemostatic agents for effective wound care and the design of innovative biomaterials to support tissue regeneration. His work contributes significantly to the advancement of medical science and technology.

👩‍🏫Technical Skills

Dr. Pan is skilled in developing and synthesizing antimicrobial materials and hemostatic agents with applications in wound healing and infection control. He is proficient in designing biomaterials for tissue regeneration and employing advanced techniques for material characterization and biomedical innovations. His expertise bridges material science and healthcare applications.

📑Top Note Publications

Title: A thermoresponsive metabolic nanomodulator for achieving photochemotherapy-sensitized cancer immunotherapy

Authors: Wu, S.-Y.; Zhu, X.-Y.; Zhang, X.; … Xu, B.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Research progress on sensitization mechanism of gemcitabine combined with other drugs in treatment of pancreatic cancer | 吉西他滨联合用药治疗胰腺癌增敏作用机制研究进展

Authors: Liu, M.; Deng, J.; Lei, D.; … Tang, S.; Xie, W.
Publication Year: 2024
Citations: 0

Title: Devastating the Supply Wagons: Multifaceted Liposomes Capable of Exhausting Tumor to Death via Triple Energy Depletion

Authors: Wang, T.-Y.; Zhu, X.-Y.; Jia, H.-R.; … Pan, G.-Y.; Wu, F.-G.
Publication Year: 2024
Citations: 1

Title: Turning dextran into antibacterial fibers: Quaternary ammonium salt for antibacterial treatment and wound healing

Authors: Pan, G.; Wang, Q.; Ding, H.; … Gao, S.; Wang, L.
Publication Year: 2024
Citations: 2

Title: Antioxidant and antibacterial hydrogel formed by protocatechualdehyde–ferric iron complex and aminopolysaccharide for infected wound healing

Authors: Deng, J.; Gao, S.; Liu, M.; Xie, W.; Pan, G.-Y.
Publication Year: 2024
Citations: 1

Dr. Chuanhui Cao | Infections | Best Researcher Award